Mesirow Financial Investment Management, Inc. Opiant Pharmaceuticals, Inc. Transaction History

Mesirow Financial Investment Management, Inc.

$4.94 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$9.52 - $13.48 $167,866 - $237,692	17,633 New	17,633 $190,000
Q2 2021 Jul 23, 2021	SELL	$10.5 - $14.19 $7,906 - $10,685	-753 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$8.2 - $14.49 $2,640 - $4,665	322 Added 74.71%	753 $8,000
Q4 2020 Jan 14, 2021	BUY	$6.87 - $8.88 $2,960 - $3,827	431 New	431 $3,000
Q3 2020 Oct 13, 2020	SELL	$7.48 - $9.54 $147,954 - $188,701	-19,780 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$8.64 - $11.87 $3,767 - $5,175	-436 Reduced 2.16%	19,780 $179,000
Q1 2020 Apr 09, 2020	BUY	$9.11 - $14.42 $184,167 - $291,514	20,216 New	20,216 $194,000

Others Institutions Holding OPNT

# of Institutions

Shares Held

300

Call Options Held

Put Options Held

View Full List

About OPIANT PHARMACEUTICALS, INC.

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

More about OPNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account